Improving understanding and treatment of leiomyosarcoma
Developmental Research Program
['FUNDING_OTHER'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-10911952
This study is looking to improve how we understand and treat leiomyosarcoma, a type of cancer, by exploring its genetics and encouraging a mix of researchers to come up with new ideas that could help patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-10911952 on ClinicalTrials.gov |
What this research studies
This research program focuses on enhancing the understanding of leiomyosarcoma, a type of cancer, through genetics and genomics. It aims to develop new diagnostic methods and treatment approaches by supporting short-range studies that generate essential data for hypothesis-driven projects. The program encourages participation from diverse researchers, particularly those from underrepresented backgrounds, to foster innovation in sarcoma research. By collaborating with established and emerging investigators, the program seeks to advance the field of cancer biology and improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with leiomyosarcoma or those at risk for this type of cancer.
Not a fit: Patients with cancers other than leiomyosarcoma may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic tools and treatment options for patients with leiomyosarcoma.
How similar studies have performed: Previous research in cancer biology has shown promise in improving treatment outcomes through genetic and genomic approaches, indicating that this program builds on established successes.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROBINSON, STEVEN — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: ROBINSON, STEVEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Biology, Cancer Center